| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 77.531 | 192.037 | 263.268 | 321.474 |
| Total Income - EUR | - | - | - | - | - | - | 77.531 | 192.037 | 263.268 | 321.474 |
| Total Expenses - EUR | - | - | - | - | - | - | 76.946 | 153.918 | 211.828 | 235.401 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 586 | 38.119 | 51.440 | 86.073 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 53 | 36.445 | 49.353 | 78.989 |
| Employees | - | - | - | - | - | - | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Ophtart Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 116.388 | 94.547 | 105.146 | 171.372 |
| Current Assets | - | - | - | - | - | - | 12.526 | 994 | 32.357 | 30.906 |
| Inventories | - | - | - | - | - | - | 11.400 | 0 | 0 | 404 |
| Receivables | - | - | - | - | - | - | 121 | 0 | 1.233 | 709 |
| Cash | - | - | - | - | - | - | 1.004 | 994 | 31.124 | 29.792 |
| Shareholders Funds | - | - | - | - | - | - | 93 | 36.539 | 85.781 | 164.291 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 128.820 | 59.002 | 51.722 | 37.987 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ophtart Med S.r.l.